Appointments   HBC Refills   Incoming Students   Graduates/Health Records
Health Services

Required Immunizations

All students are required to comply with the immunization laws that are established by New York State. New York State Public Law 2651 requires that all students who are enrolled at least half-time (six credits), and who were born on or after January 1, 1957 provide the College with documentation of immunity to measles (rubeola), mumps, and rebella (German measles).

Skidmore College also requires dates of completion of your primary Polio vaccinations, and a Tetanus Diphtheria or Tetanus-Diphtheria-Pertussis booster within the past 10 years.

NEW STUDENTS registering for the first time have 30 days (45 days for out of state residents) from the first day of classes to comply. Students who do not comply will have a hold placed on their account, preventing registration for their second semester.

Information Link                                        


Vaccination Schedule


Cost at Health Services

MMR (Measles, Mumps, & Rubella)


Two doses of MMR at least 28 days apart after 12 months of age.





Primary series in childhood (4 doses: DT, DTaP, DTP, or Td) Booster doses:For adolescents 11-18 and adults 19-64: single dose of Tdap. Tdap can be administered regardless of interval since the last tetanus or diphtheria toxoid-containing vaccine. Routine booster dose intervals: Adults should receive decennial Td boosters, beginning 10 years after receiving Tdap, until guidance on subsequent Tdap booster doses is available. Tetanus prophylaxis in wound management: For all age groups, patients who require a tetanus toxoid containing vaccine as part of wound management should receive Tdap instead of Td if they have not previously received Tdap. If Tdap is not available or was administered previously, Td should be administered.


$20 Td


$40 TDaP



Primary series in childhood with IPV alone, OPV alone, or IPV/OPV sequentially; IPV booster only if needed for travel after age 18 years.



Religious Exemptions are available. Click here for Policy.

Recommended Immunizations

Community living on a college campus supports an environment where sharing of illness can occur. Therefore, although they are not required, Health Services strongly recommends immunization against both Hepatitis B and Bacterial Meningitis.

New York State Public Health Law 2167, established July 22nd, 2003 requires academic institutions to distribute information pertaining to the meningococcal disease vaccination to all students registered for six or more credits. Although a vaccine is not mandatory, all students are required to submit a response as to the status of the meningococcal disease.

Information Link                                                 


Vaccination Schedule


Cost at Health Services

Bacterial Meningitis


Initial dose of conjugate vaccine: 11-12 yrs of age

Booster dose: 16 yrs of age

If initial dose given age 13-15 yrs: booster dose at 16-18 yrs of age

If initial dose given age ≥16 yrs, no booster dose required.

All other persons at increased risk for meningococcal disease (e.g., microbiologists or travelers to an epidemic or highly endemic country) should receive a single primary dose.

The minimum interval between doses of meningococcal conjugate vaccine is 8 weeks. Routine vaccination of healthy persons who are not at increased risk for exposure is not recommended after age 21 years.



Hepatitis A


Given as a series of 2 doses (given at 0, 6-12 mo.) for age 12 months or greater.

Many people are recommended to receive hepatitis A vaccine, including people at increased risk for exposure to hepatitis A virus infection and people who are more likely to get seriously ill if infected with the virus. According to CDC recommendations, people who should be vaccinated include:

  • All children starting at age 1 year (12–23 months)
  • People age 12 months or older who are traveling to or working in an area of the world except the United States, Canada, Western Europe, Japan, New Zealand, and Australia
  • Men who have sex with men
  • Users of illicit drugs, injectable or noninjectable
  • People who anticipate having close personal contact with an international adoptee from a country of high or intermediate endemicity during the first 60 days following the adoptee's arrival in the United States
  • People who have blood clotting disorders
  • People who work with HAV-infected primates or with hepatitis A virus in a research laboratory setting (no other groups have been shown to be at increased risk for HAV infection because of occupational exposure)
  • People with chronic liver disease
  • Any person who wishes to be protected from hepatitis A virus infection



Hepatitis B


Given as a series of 3 age appropriate doses (given at 0, 1-2 mo., and 6-12 mo.) at any age. Adolescents age 11-15 years can be given 2 adult doses (given at 0, and 4-6mo.).

Hepatitis B vaccination should be administered to all unvaccinated people traveling to areas with intermediate or high prevalence of chronic hepatitis B. Hepatitis B vaccination is recommended for all US residents who work in health care settings that involve potential exposure to human blood. All unvaccinated children and adolescents (aged <19 years) should receive hepatitis B vaccine. Regardless of destination, all people who may engage in practices that place them at risk for HBV infection during travel (such as men who have sex with men, injection drug users, anyone who had a sexually transmitted disease or has had more than one sexual partner in the previous 6 months) should receive hepatitis B vaccination, if previously unvaccinated. Any adult seeking protection from HBV infection should be vaccinated; acknowledgment of a specific risk factor is not a requirement for vaccination.



Hepatitis A & B combined-Twinrix


Twinrix is indicated for vaccination of persons aged >18 years against hepatitis A and B. Any person in this age group having an indication for both hepatitis A and B vaccination can be administered Twinrix. Primary vaccination consists of three doses, given on a 0-, 1-, and 6-month schedule, the same schedule as that used for single antigen hepatitis B vaccine.



HPV (Gardasil) Human Papilloma Virus


Females 11 or 12 years old, females age 13-26 years old who have not received the vaccine previously, and males 9-26 years old: three doses at 0, 2, and 6 months for the quadrivalent vaccine.

HPV vaccine is an inactivated (not live) vaccine which protects against 4 major types of HPV. These include 2 types that cause about 70% of cervical cancer and 2 types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer.



Varicella (Chicken Pox)


Two doses of varicella-containing vaccine at least 12 weeks apart if vaccinated between 1 and 12 years of age and at least 4 weeks apart if vaccinated at age 13 years or older.

Varicella vaccine is recommended for postexposure administration for healthy unvaccinated people aged ≥12 months without other evidence of immunity.



Oral Typhoid Vaccine (Vivotif Berna)


For those who are at increased risk because they are traveling to an area where this infection is more common, have been in contact with infected individuals, or work in an environment that increases their risk .The oral vaccine offers protection against typhoid fever for 5 years.



Tuberculosis Testing/PPD – available for $10.00; requires a return visit for interpretation of results in two to three days. PPD testing is often required for travel, internships, employment in healthcare and childcare facilities. Health Services will provide a copy of PPD results to students upon request.             

Further information can be found at